Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2985 Target Snapshot

Potassium voltage-gated channel subfamily KQT member 2 · SINGLE PROTEIN · Mus musculus

53Compounds
16Assays
1Approved Drugs
27.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9Z351. Use UniProt Q9Z351 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9Z351 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Potassium voltage-gated channel subfamily KQT member 2 as ChEMBL target CHEMBL2985, mapped to UniProt Q9Z351. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Potassium voltage-gated channel subfamily KQT member 2
SINGLE PROTEIN · Mus musculus
As of 2026-09-14
ChEMBL target ID
CHEMBL2985
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9Z351
Potassium voltage-gated channel subfamily KQT member 2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Potassium voltage-gated channel subfamily KQT member 2 is the right protein anchor across sources, using UniProt Q9Z351 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPotassium voltage-gated channel subfamily KQT member 2
UniProt AccessionQ9Z351
Component TypeProtein
Sequence Length759 aa

Potassium voltage-gated channel subfamily KQT member 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Potassium voltage-gated channel subfamily KQT member 2, mapped to UniProt Q9Z351. Sequence length is 759 aa.

Mapped IDQ9Z351
Review namePotassium voltage-gated channel subfamily KQT member 2
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

EC5027.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2440363 9.05 EC50 0.9 Preclinical
CHEMBL401942 8.62 EC50 2.4 Preclinical
CHEMBL361184 8.0 EC50 10.0 Preclinical
CHEMBL180886 7.7 EC50 20.0 Preclinical
CHEMBL176931 7.22 EC50 60.0 Preclinical
CHEMBL179854 6.92 EC50 120.0 Preclinical
CHEMBL174891 6.7 EC50 200.0 Preclinical
CHEMBL182734 6.48 EC50 330.0 Preclinical
CHEMBL183908 6.43 EC50 370.0 Preclinical
CHEMBL41078 6.18 EC50 663.0 Preclinical
Distribution

pChEMBL Value Distribution

2
5.0
8
5.5
4
6.0
2
6.5
3
7.0
2
7.5
2
8.0
1
8.5
1
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

16
Total Assays
14
Tested Compounds
2
Assay Types
Functional — 13 assays, 14 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 12 14 6.4
assay format 1 0
Binding — 3 assays, 7 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 3 7 7.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine